RAF1 and cancer: Hatzivassiliou and colleagues found that RAF inhibitors, while effective in blocking signaling in BRAFV600E mutant (MT) cancer cell lines, paradoxically increased cell proliferation in BRAFWT cancer cell lines (Hatzivassiliou et al., 2010).